Regeneron Pharmaceuticals, Inc.
NUCLEIC ACID CONSTRUCTS AND METHODS OF USE

Last updated:

Abstract:

The present disclosure provides bidirectional nucleic acid constructs that allow enhanced insertion and expression of a nucleic acid sequence of interest, e.g., encoding a therapeutic agent such as a polypeptide.

Status:
Application
Type:

Utility

Filling date:

16 Apr 2021

Issue date:

14 Oct 2021